Skip to main content

Table 1 .

From: Estimation of potential cost-savings related to the implementation of perioperative hemodynamic goal-directed therapy

Actual morbidity rate no pGDT (%)

10

20

30

40

50

60

Expected morbidity rate pGDT (%)

3.5 to 5.5

7 to 11

11 to 17

14 to 22

18 to 28

21 to 33

Expected cost reduction/US patient ($)

808 to 1,167

1,615 to 2,333

2,423 to 3,500

3,231 to 4,667

4,039 to 5,833

4,846 to 7,000

Expected cost reduction/CH patient ($)

1,550 to 2,239

3,100 to 4,478

4,478 to 6,545

6,200 to 8,956

7,578 to 11,023

9,300 to 13,434